Heavy menstrual bleeding affects roughly one in four people who menstruate at some point in their lives, and the causes range from structural growths in the uterus to hormonal imbalances, bleeding disorders, and thyroid problems. Clinically, “heavy” generally means soaking through a pad or tampon every hour or two for several consecutive hours, passing clots larger than a coin, or bleeding that lasts more than seven days. The tricky part is that many people grow up assuming their heavy flow is just how periods work, which delays diagnosis and treatment sometimes for years. Understanding what might be driving the bleeding is the first step toward getting it under control.
Fibroids and Adenomyosis
The most common structural culprits behind heavy periods are uterine fibroids, which are noncancerous growths in or on the uterine wall. Fibroids can distort the blood vessel network inside the uterus, creating abnormal vascular patterns and areas where normal blood flow gets blocked, sometimes forming what researchers describe as “venous lakes.” These changes in blood-vessel architecture, along with the increased local action of growth factors that affect blood vessels, help explain why a fibroid-bearing uterus can bleed so much more than one without them.1PubMed Central. Uterine Fibroids (Leiomyomata) and Heavy Menstrual Bleeding Not all fibroids cause heavy bleeding; location matters a lot. Submucosal fibroids, which grow into the uterine cavity, are the biggest offenders. Intramural fibroids within the muscle wall can also contribute, while subserosal fibroids on the outer surface often cause pressure symptoms without much effect on flow.
Adenomyosis is the other major structural player and is often underdiagnosed. In adenomyosis, tissue similar to the uterine lining grows into the muscular wall of the uterus itself. This causes the uterus to enlarge and contract abnormally. A systematic review and meta-analysis found that adenomyosis is associated with both increased frequency and increased strength of uterine contractions, along with abnormal uterine bleeding, painful periods, and impaired fertility.2PubMed Central. Uterine Contractility Changes in Adenomyosis: Evidence from a Systematic Review and Meta-Analysis Adenomyosis and fibroids frequently coexist, which can make it hard to pinpoint which one is driving the heaviest bleeding.
Hormonal Imbalances and Anovulation
When your body does not ovulate during a cycle, it still produces estrogen but does not produce the progesterone that normally follows ovulation. This matters because progesterone is what stabilizes the uterine lining and controls the timing and completeness of its shedding. Without it, estrogen keeps stimulating the lining to grow thicker and thicker. When that overgrown lining finally breaks down, it does so unevenly, sometimes causing prolonged or unusually heavy bleeding. This pattern of chronic unopposed estrogen can also place the endometrium at risk for precancerous changes over time.3JAMA. Clinical Manifestations and Treatment of Dysfunctional Uterine Bleeding
Anovulatory cycles are especially common at the two ends of reproductive life. Teenagers whose hormonal systems are still maturing may go months without ovulating, leading to unpredictable and sometimes alarmingly heavy periods. People approaching menopause experience a similar hormonal instability. During the perimenopausal years, previously regular hormone fluctuations become erratic, and heavy menstrual bleeding and iron deficiency anemia are recognized complications of this transition.4PubMed Central. Addressing the perimenopause: what’s blood got to do with it? Conditions like polycystic ovary syndrome (PCOS) can cause anovulation at any age, and the metabolic disruptions that accompany PCOS, including insulin resistance, tend to worsen menstrual irregularities.5PubMed Central. Association between insulin resistance and abnormal menstrual cycle in Saudi females with polycystic ovary syndrome
Bleeding Disorders
This is one of the most under-recognized causes of heavy periods, especially in younger people. Von Willebrand disease is the most common inherited bleeding disorder, and it frequently shows up first as heavy menstrual bleeding. A multicenter prospective study of adolescents referred for heavy periods found that about a third had an underlying bleeding disorder.6PubMed Central. Bleeding disorders in adolescents with heavy menstrual bleeding in a multicenter prospective US cohort That is a strikingly high number, and it underscores how often this possibility gets overlooked.
Among people diagnosed with von Willebrand disease, heavy menstrual bleeding is extremely common. One retrospective study found that 93% of women with the condition reported heavy periods during at least one stage of life, with 85% experiencing them during adolescence.7PubMed Central. Prevalence and Impact of Heavy Menstrual Bleeding in Women With von Willebrand Disease Across Age Groups: A Retrospective Study The rates tend to decrease with age, dropping to roughly 45% in the thirties and 36% from 40 to 55, but the impact is significant at every stage. Most of those studied said heavy bleeding negatively affected their school or work performance, social activities, and physical activities. Even with treatment using hormonal therapy or blood-clotting medications, more than half still had iron deficiency. A separate cohort study found broadly similar patterns, with about two-thirds of participants reporting heavy bleeding.8Research and Practice in Thrombosis and Haemostasis. Prevalence of heavy menstrual bleeding, iron deficiency, iron deficiency anemia, and treatment in women with von Willebrand disease—a cohort study
Von Willebrand disease is not the only bleeding disorder that causes heavy periods. Platelet function defects, clotting factor deficiencies, and certain inherited conditions affecting the blood’s ability to form stable clots can all contribute. If your periods have been heavy since they first started, or if you also bruise easily, bleed for a long time after cuts, or have had significant bleeding after dental work or surgery, a bleeding disorder is worth investigating.
Thyroid Disease and Other Systemic Causes
Your thyroid affects far more than metabolism and energy levels. Hypothyroidism, where the thyroid gland produces too little hormone, can shift the body’s clotting system toward a state where blood clots less easily and existing clots break down faster, which increases bleeding risk.9PubMed Central. Menorrhagia as main presentation sign of severe hypothyroidism in a pediatric patient: a case report In one study at a tertiary care center, roughly 38% of patients with hypothyroidism had abnormal menstrual patterns, compared to about 15% of those with normal thyroid function.10National Journal of Laboratory Medicine. Effect of Hypothyroidism on Menstrual Cycle Pattern and Fertility at a Tertiary Care Centre in South India Those abnormalities included various patterns, not just heavier bleeding, but the connection is well established. A simple blood test for thyroid-stimulating hormone (TSH) can identify or rule out this cause.
Other systemic conditions can also contribute. Liver disease, kidney disease, and certain medications like anticoagulants (blood thinners) can worsen menstrual bleeding. Copper intrauterine devices (IUDs) are a well-known cause of heavier periods, particularly in the first several months after insertion. If your periods became noticeably heavier after starting a new medication or device, that is worth mentioning to your doctor.
What Happens at the Tissue Level
Even when no structural or systemic cause is found, some people simply bleed more because of how their uterine lining behaves at a microscopic level. The endometrium produces its own local clotting and anti-clotting factors, and the balance between them determines how quickly shed tissue stops bleeding. Prostaglandins, which are chemical messengers made in the uterine lining, play a role in regulating this balance. Research on endometrial blood vessel cells has shown that prostaglandin E2 helps regulate the clot-breakdown system in people with normal menstrual flow, but this regulatory mechanism appears to be disrupted in people with heavy bleeding.11PubMed. Prostaglandin E(2) regulates the plasminogen activator pathway in human endometrial endothelial cells: a new in vitro model to investigate heavy menstrual bleeding In practical terms, the lining in heavy bleeders may break down clots faster than it should, preventing the small “plugs” that normally seal off blood vessels during a period from doing their job.
Iron Deficiency and Why It Matters
The single most common consequence of heavy periods is iron deficiency, and it deserves its own attention because it creates a vicious cycle of worsening symptoms. Heavy menstrual bleeding is the leading cause of iron deficiency, including iron deficiency anemia, in people of reproductive age.12PubMed. Heavy menstrual bleeding, iron deficiency, and iron deficiency anemia: Framing the issue The symptoms of low iron, including fatigue, brain fog, dizziness, shortness of breath, and pale skin, are often attributed to the period itself or to being “run down,” so people adapt rather than seek help.
What makes this especially frustrating is that iron deficiency can persist even when heavy bleeding is being treated. In the study of women with von Willebrand disease mentioned earlier, 54% had iron deficiency despite actively using hormonal therapy or clotting agents.7PubMed Central. Prevalence and Impact of Heavy Menstrual Bleeding in Women With von Willebrand Disease Across Age Groups: A Retrospective Study Iron stores can take months to rebuild even after bleeding has improved. If you have heavy periods, it is worth asking for a ferritin test (which measures stored iron) rather than just a basic blood count, because your hemoglobin can look normal even when your iron reserves are depleted.
Non-Hormonal Medications
If you want to reduce bleeding without using hormones, two proven options stand out. Tranexamic acid works by slowing the breakdown of blood clots that form in the uterine lining. It reduces menstrual blood loss by roughly 26% to 60% and has been shown to outperform placebo, anti-inflammatory painkillers, and certain short-course progestins.13PubMed Central. Tranexamic acid for the treatment of heavy menstrual bleeding: efficacy and safety You take it only during the heaviest days of your period, which appeals to people who prefer not to use daily medication.
Nonsteroidal anti-inflammatory drugs (NSAIDs) like mefenamic acid and ibuprofen also reduce menstrual bleeding. One study found that mefenamic acid decreased menstrual blood loss by about 40% compared to placebo, likely by improving platelet function and increasing blood vessel constriction in the uterine lining.14PubMed. Effects of mefenamic acid on menstrual hemostasis in essential menorrhagia NSAIDs have the added benefit of reducing cramps, making them a practical two-for-one option. However, neither tranexamic acid nor NSAIDs address any underlying structural cause, so they are best suited for people whose heavy bleeding is not driven by something like a large fibroid that needs separate treatment.
Hormonal Treatments
The levonorgestrel-releasing intrauterine system, commonly known by brands like Mirena, is widely considered the most effective medical treatment for heavy menstrual bleeding. It delivers a small amount of progestin directly to the uterine lining, thinning it dramatically. Studies consistently show it reduces menstrual volume scores significantly within the first few months, while hemoglobin levels rise as blood loss decreases.15PubMed Central. Effect of Mirena Intrauterine Device on Endometrial Thickness, Quality of Life Score, and Curative Effect in Patients with Perimenopausal Abnormal Uterine Bleeding Many users eventually stop menstruating altogether. A Cochrane review found that the hormonal IUD outperformed both short-cycle and long-cycle oral progestins for reducing menstrual blood loss.16Cochrane Database of Systematic Reviews. Oral progestogen therapy for heavy menstrual bleeding
Combined oral contraceptive pills, which contain both estrogen and a progestin, also thin the lining and regulate cycles. Extended or continuous regimens, where you skip the placebo week, reduce the number of bleeding episodes per year. Progestin-only pills, particularly newer high-dose formulations, have gained recognition for their ability to control bleeding effectively as well. The expanding range of progestins available has allowed for more tailored approaches, with different progestin types offering distinct benefit and risk profiles.17PubMed Central. The progestin revolution 2: progestins are now a dominant player in the tight interlink between contraceptive protection and bleeding control-plus more
GnRH Antagonists for Fibroid-Related Bleeding
A newer class of medications called GnRH antagonists has changed the treatment landscape for people whose heavy bleeding is caused by fibroids. These drugs work by reducing estrogen levels, which shrinks fibroids and thins the uterine lining. They are often paired with low-dose hormonal “add-back” therapy to prevent menopausal side effects like hot flashes and bone loss.
In two large randomized trials, the GnRH antagonist elagolix combined with add-back therapy achieved meaningful bleeding reduction in roughly 69% to 77% of participants, compared to about 9% to 10% with placebo.18PubMed. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids A meta-analysis pooling data from multiple trials of GnRH antagonists (including relugolix and linzagolix alongside elagolix) found that patients in the treatment groups were about five times more likely to achieve bleeding control than those on placebo, and fibroid volume shrank by an average of roughly 27%.19PubMed Central. Efficacy of GnRH antagonists in the treatment of uterine fibroids: a meta-analysis Linzagolix, another drug in this class, was shown to lead to no menstrual bleeding at all by week five when used alone, and starting add-back therapy from the beginning offered better bleeding control without the hot flashes that come from unopposed estrogen suppression.20PubMed. Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding
These medications represent a significant advance because, before them, the options for fibroid-related heavy bleeding were essentially the hormonal IUD (which does not shrink fibroids), older injectable GnRH agonists with more severe side effects, or surgery. GnRH antagonists come in pill form, work quickly, and can serve as either a long-term treatment or a bridge to surgery.
Surgical and Procedural Options
When medication is not enough, or when the underlying cause is structural and unlikely to respond to medication alone, several procedures can help.
- Endometrial ablation: This procedure destroys the uterine lining using heat, cold, or other energy sources. It is minimally invasive and done as an outpatient procedure. It works well for people who do not plan future pregnancies, but the five-year reintervention rate is about 33%, the highest among the common fibroid procedures.
- Myomectomy: This surgically removes fibroids while preserving the uterus, making it the go-to choice for people who want to keep the option of pregnancy. It had the lowest twelve-month reintervention rate at about 4%, with a five-year rate around 19%.
- Uterine artery embolization (UAE): A radiologist threads a tiny catheter into the arteries feeding the fibroids and injects particles that block blood flow, causing the fibroids to shrink. It falls between the other two options for reintervention, with a five-year rate of roughly 24%.
Those reintervention figures come from a large study comparing outcomes across all three approaches.21PubMed Central. Reintervention Rates After Myomectomy, Endometrial Ablation, and Uterine Artery Embolization for Patients with Uterine Fibroids A separate ten-year follow-up of a randomized trial comparing uterine artery embolization to hysterectomy found that about two-thirds of UAE-treated patients avoided hysterectomy entirely over a decade, and quality of life remained comparable between the two groups.22PubMed. Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 10-year outcomes from the randomized EMMY trial Hysterectomy, the removal of the uterus, remains the only definitive cure for heavy menstrual bleeding since it eliminates menstruation entirely. But given the long recovery and permanence, it is generally reserved for people who have completed childbearing and have not responded to other treatments.
Why So Many People Wait Too Long to Seek Help
One of the most persistent barriers to treatment is the widespread normalization of heavy periods. Research on adolescents with heavy menstrual bleeding found that many simply assumed their experience was normal, lacked sufficient knowledge to recognize symptoms that warranted medical attention, or faced embarrassment, family advice to “wait it out,” school-related concerns, and discomfort with talking to a healthcare provider.23Link Medical Journal. Menstrual Health Literacy and Delay in Care-Seeking Among Adolescents with Heavy Menstrual Bleeding This normalization is not limited to teenagers. Many adults who have bled heavily for years have simply built their lives around managing it, buying industrial quantities of menstrual products, doubling up protection, avoiding white clothing, and declining social invitations during their period.
The problem with waiting is not just discomfort and inconvenience. Undiagnosed bleeding disorders, thyroid conditions, and structural causes like fibroids do not resolve on their own. Iron deficiency accumulates over time, dragging down energy, cognitive function, and overall health. And as noted earlier, about one in three adolescents referred for evaluation of heavy periods turns out to have a bleeding disorder, a diagnosis that matters well beyond menstruation because it affects surgical risk, pregnancy outcomes, and dental care for the rest of their lives.6PubMed Central. Bleeding disorders in adolescents with heavy menstrual bleeding in a multicenter prospective US cohort
Why Humans Menstruate at All
This may seem like a tangent, but it is a genuinely interesting one. Menstruation is rare in the animal kingdom. Most mammals reabsorb their uterine lining rather than shedding it. Humans, some other primates, certain bats, and the elephant shrew are among the few species that menstruate visibly, which has led researchers to ask why we evolved this apparently wasteful process.
The leading explanation centers on something called spontaneous decidualization, where the uterine lining transforms in preparation for a potential pregnancy every cycle regardless of whether an embryo is present. In most mammals, this transformation only happens in response to signals from an implanting embryo. In menstruating species, it evolved as a maternal defense mechanism against the highly invasive nature of the embryo’s placenta, giving the mother’s body more control over the implantation process.24PubMed Central. The evolution of menstruation: a new model for genetic assimilation When no pregnancy occurs, the transformed lining is shed because it has already undergone changes that cannot simply be reversed and reabsorbed efficiently.
A complementary theory links menstruation directly to childbirth. In humans and Old World primates, the specialized spiral arteries in the uterine wall evolved alongside the deeply invasive hemochorial placenta. During birth, progesterone withdrawal causes these arteries to constrict, allowing the placenta to detach without catastrophic maternal hemorrhage. In a non-pregnant cycle, the same progesterone withdrawal from a degenerating corpus luteum triggers the same arterial constriction, resulting in menstruation. From this perspective, monthly periods are essentially the reproductive system rehearsing the vascular shutdown it uses during placental delivery.25PubMed. The Link Between Human Menstruation and Placental Delivery: A Novel Evolutionary Interpretation Neither theory fully explains why some individuals bleed so much more than others, but they offer a framework for understanding that menstruation is not a design flaw. It is a byproduct of reproductive adaptations that were, on balance, worth keeping.